Back to results
US 2025/0179059 A1Published application
Anticancer compounds
AssigneesThe Regents of the University of California, Poseidon Innovation, LLC
InventorsAndrew K. Shiau, Mehmet Kahraman, Michael J. Bishop
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of formula (I): and pharmaceutically acceptable salts thereof. The compounds of the invention are BDII-selective inhibitors of BET proteins, and have therapeutic potential for treating cancer, acute kidney disease, and viral infections, among other diseases.
Claims11
(canceled)
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.